Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.70 USD
Change Today -0.02 / -0.74%
Volume 1.0M
CYTR On Other Exchanges
As of 8:10 PM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

D. Scott Wieland Ph.D., M.B.A.

Senior Vice President of Drug Development, CytRx Corporation
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 4 different industries.

As of Fiscal Year 2014


Dr. D. Scott Wieland, Ph.D., MBA has been the Senior Vice President of Drug Development at CytRx Corporation since December 2008, which he joined in 2005. Dr. Wieland served as Scientific Advisor of Regulatory Affairs of ProteoTech, Inc. He has fifteen years of experience in the biopharmaceutical industry. His experience ranges across all aspects of drug development with a focus on neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, and stroke. ...

Read Full Background

Corporate Headquarters*

11726 San Vicente Boulevard
Los Angeles, California 90049

United States

Phone: 310-826-5648
Fax: 310-826-6139

Board Members Memberships*

There is no Board Members Memberships data available.


MA 1984
The University of Arizona
PhD 1987
The University of Arizona
MBA 1998
Webster University
BS 1981
University of California, Santa Barbara

Other Affiliations*

Annual Compensation*

Total Annual Compensation$650,000

Stock Options*

Exercisable Options203,096
Unexercisable Options333,333
Total Number of Options536,429

Total Compensation*

Total Annual Cash Compensation$650,000
Total Short Term Compensation$650,000
Total Calculated Compensation$951,000
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CYTR:US $2.70 USD -0.02


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CYTRX CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at